Corbus Pharmaceuticals Holdings Inc (CRBP)
38.15
+0.90
(+2.42%)
USD |
NASDAQ |
May 02, 13:57
Corbus Pharmaceuticals Holdings Cash from Operations (Quarterly): -6.009M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.009M |
| September 30, 2023 | -7.176M |
| June 30, 2023 | -7.800M |
| March 31, 2023 | -15.12M |
| December 31, 2022 | -7.455M |
| September 30, 2022 | -7.245M |
| June 30, 2022 | -12.23M |
| March 31, 2022 | -10.62M |
| December 31, 2021 | -9.703M |
| September 30, 2021 | 0.857M |
| June 30, 2021 | -17.53M |
| March 31, 2021 | -21.81M |
| December 31, 2020 | -18.22M |
| September 30, 2020 | -27.25M |
| June 30, 2020 | -26.61M |
| March 31, 2020 | -27.60M |
| December 31, 2019 | -22.56M |
| September 30, 2019 | -17.09M |
| June 30, 2019 | -16.39M |
| March 31, 2019 | 10.32M |
| Date | Value |
|---|---|
| December 31, 2018 | -14.06M |
| September 30, 2018 | -8.847M |
| June 30, 2018 | -5.557M |
| March 31, 2018 | -1.599M |
| December 31, 2017 | -9.114M |
| September 30, 2017 | -6.332M |
| June 30, 2017 | -5.715M |
| March 31, 2017 | -6.636M |
| December 31, 2016 | -5.479M |
| September 30, 2016 | -3.051M |
| June 30, 2016 | -2.527M |
| March 31, 2016 | -2.515M |
| December 31, 2015 | -0.881M |
| September 30, 2015 | -2.483M |
| June 30, 2015 | 0.0195M |
| March 31, 2015 | -1.280M |
| December 31, 2014 | -1.321M |
| September 30, 2014 | -0.5783M |
| June 30, 2014 | -0.3217M |
| March 31, 2014 | -0.14M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.60M
Minimum
Mar 2020
0.857M
Maximum
Sep 2021
-14.61M
Average
-15.12M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Spectral AI Inc | -5.338M |
| Panbela Therapeutics Inc | -3.08M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 10.39M |
| Cash from Financing (Quarterly) | -1.905M |
| Free Cash Flow | -36.10M |
| Free Cash Flow Per Share (Quarterly) | -1.358 |
| Free Cash Flow Yield | -21.87% |